NO!! because - as you well know- you can’t take the results of one arm in one study (n> 800), compare with another study (lupin n= 56) especially as there is much more imprecision in small sample (remind us again what the median survival confidence levels are in lupin?) , and go hey we’re X% better. It’s dumb, it’s unscientific and would make any credible statistician cringe. Sure it’s useful knowing what the other studies are showing and setting a context, but this knee jerk need to manufacture statistics for a headline is pure BS.
I know you’re emotionally connected to Nox and self appointed spokesperson for them on this forum (or maybe a Nox employee??) but stop trying to make up data or conclusions that aren’t valid or claim somethings “incontrovertible” when it clearly isn’t - please - coz it just gets exposed!!
btw: any update on the Covid trial cytokine analyses?
a bientot
NO!! because - as you well know- you can’t take the results of...
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.005(4.76%) |
Mkt cap ! $32.14M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 11.5¢ | 11.0¢ | $18.94K | 171.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 66800 | 1 |
View Market Depth
| Last trade - 14.48pm 08/11/2024 (20 minute delay) ? |
| NOX (ASX) Chart |